BIOL Biolase
- 0.1607
- +0.0017+1.07%
- 0.1595
- -0.0012-0.75%
Biolase News
Express News | BIOLASE -on May 14, Received Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard From Nasdaq
Maxim Group Downgrades Biolase (BIOL) to a Hold
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersDelcath Systems (NASDAQ:DCTH) stock rose 33.2% to $7.19 during Tuesday's regular session. The company's market cap stands at $199.8 million. As per the news, the Q1 earnings report came out tod
Biolase Price Target Maintained With a $0.40/Share by Benchmark
Biolase Price Target Maintained With a $0.40/Share by Benchmark
Express News | Benchmark Reiterates Speculative Buy on Biolase, Maintains $0.4 Price Target
Biolase Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 159.91% Benchmark → $0.4 Reiterates Speculative Buy → Speculative Buy 04/01/2024 2499.09% Ascen
Wall Street Set to Open Flat Tuesday as Key Inflation Gauge Rises More Than Expected
US stocks look set to open flat in Tuesday's session as a main indicator of inflation came in higher than expected earlier in the morning. The Dow Jones Industrial Average futures were up 0.06%, S&P 5
Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Shares of Alcon Inc. (NYSE:ALC) rose sharply in today's pre-market trading following better-than-expected first-quarter earnings.Alcon posted adjusted earnings of 78 cents per share, beating market ex
Top Premarket Decliners
Augmedix (AUGX) shares plunged 38% in recent Tuesday premarket activity after Evercore ISI downgraded the stock to in line from outperform. Inotiv (NOTV) stock fell 34% after Jefferies downgraded it t
Earnings Call Summary | Biolase(BIOL.US) Q1 2024 Earnings Conference
The following is a summary of the BIOLASE, Inc. (BIOL) Q1 2024 Earnings Call Transcript:Financial Performance:BIOLASE reported a significant growth in consumable sales, marking a 14% increase compared
BIOLASE, Inc. (BIOL) Q1 2024 Earnings Call Transcript
BIOLASE, Inc. (BIOL) Q1 2024 Earnings Call Transcript
Biolase | 10-Q: Quarterly report
Biolase Shares Are Trading Higher After the Company Reported Mixed Q1 Financial Results.
Biolase Shares Are Trading Higher After the Company Reported Mixed Q1 Financial Results.
Earnings Flash (BIOL) BIOLASE Posts Q1 Revenue $10.1M, Vs. Street Est of $10M
04:08 PM EDT, 05/13/2024 (MT Newswires) -- Earnings Flash (BIOL) BIOLASE Posts Q1 Revenue $10.1M, vs. Street Est of $10M
Express News | Biolase Q1 2024 Adj EPS $(0.36) Misses $(0.17) Estimate, Sales $10.131M Beat $9.996M Estimate
Express News | BIOLASE Q1 Net Income USD -6.485 Million
Express News | BIOLASE Q1 Revenue USD 10.131 Million
Express News | BIOLASE Q1 Income From Operations USD -4.526 Million
Express News | BIOLASE Q1 Operating Expenses USD 7.862 Million
Express News | BIOLASE Q1 Pretax Profit USD -6.466 Million
Analysis
Price Target
No Data
